You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025

By Inderes
Antti Vuolanto, CEO, talks about biotechnology company Herantis Pharma as an investment.
Life Science Night 2025
15:30 Keynote – Antti Siltanen, Inderes (link)
15:50 Orion Pharma – Tuukka Hirvonen, Head of Investor Relations (link)
16:15 Aiforia – Jukka Tapaninen, CEO (link)
16:40 Herantis Pharma – Antti Vuolanto, CEO (link)
Life Science Night December 9, 2025 (link)
Life Science Night December 2, 2024 (link)